Literature DB >> 15659868

Pancreatic involvement in Von Hippel-Lindau disease.

Mustafa Eras1, Mustafa Yenigun, Cengiz Acar, Baki Kumbasar, Fuat Sar, Turgay Bilge.   

Abstract

BACKGROUND: Involvement of the pancreas in Von Hippel-Lindau disease that is a tumor predisposing syndrome mentioned in literature with some morbid and mortal progression. AIMS: For evaluation the faith of the pancreatic involvement in VHL disease we analysed our patient population with VHL disease.
MATERIALS AND METHODS: 12 of the 56 patients that were evaluated in our institute with the diagnosis of Von Hippel-Lindau disease had pancreatic involvement. They are periodically examined for 5 years follow up period. Their retrospective analysis was accomplished. RESULTS AND
CONCLUSIONS: Pancreatic involvement in our patient population disclosed lesions that were multicysts or serous cystadenomas. During follow up period, we did not observe significant morbidity related to pancreatic involvement. Repeated radiological examination of pancreatic lesions disclosed insignificant modifications such as slight increase or decrease in size. Whereas we considered morbidity and mortality related to renal and central nervous system pathologies in VHL disease. Shortly, even pancreatic involvement in VHL disease requires close clinical follow up, morbidity and mortality in this case is not severe as in renal and the central nervous system involvement.

Entities:  

Mesh:

Year:  2004        PMID: 15659868

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  2 in total

1.  Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease.

Authors:  Kenji Tamura; Isao Nishimori; Tetsuhide Ito; Ichiro Yamasaki; Hisato Igarashi; Taro Shuin
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

2.  Pancreatic involvement in Korean patients with von Hippel-Lindau disease.

Authors:  Kwang Hyuck Lee; Jae Seung Lee; Bum Jin Kim; Jong Kyun Lee; Seong Hyun Kim; Seung Hoon Kim; Kyu Taek Lee
Journal:  J Gastroenterol       Date:  2009-03-31       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.